Announcement of the OH AMR Transnational Partnership Call for Proposals

The Ministry of Health (hereinafter “MoH”) is publishing onNovember 19, November 19, 2026, in accordance with Act No. 130/2002 Coll., on the Support of Research, Experimental Development, and Innovation from Public Funds and on Amendments to Certain Related Acts (the Act on the Support of Research, Experimental Development, and Innovation), as amended (hereinafter referred to as the “Act”),

transnational partnership call OH AMR (European Partnership on One Health Antimicrobial Resistance): “Understand, Model, and Stop AMR Transmission” (OH AMR 2027)

Call 2027

Date of Announcement of Results
, November 2027

National budget allocation for the call
500 000 EUR

Maximum amount of support per project
250 000 EUR

Maximum aid intensity per project
Table: Maximum possible aid intensity by type of entity and type of research (according to the current version Methodology: European Partnerships in Health)

Applicants
nd a research organization, a company, or a patient organization


project duration: 3 years / 36 months 

Deadlines for submitting project proposals:
Pre-proposals: February 1, 2027, 1:00 p.m. CET
Full proposals: June 23, 2027, 1:00 p.m. CEST

Those interested can participate inan international informational webinar, which will take placeon November 25, 2026 (from 1:30 p.m. to 3:30 p.m. CET). Registrationis available at this link:REGISTRATION

Documents

Conditions for a Czech Applicant's Participation in OHAMR 2027

Methodology: European Partnerships for Health

Subprogram 3: European Partnerships in Health – effective May 22, 2024

Mandatory attachments of the Czech applicant for Phase 1 (pre-proposals)

  1. Affidavit on behalf of the tenderer or co-tenderer (PO)
  2. Affidavit on behalf of the tenderer or co-tenderer (FO)
  3. Affidavit for research organisations (if applicable)
  4. Affidavit of consortium composition (only if a Czech company is represented in the project)
  5. Budget tableAZV ČR Application Form)

Mandatory annexes of the Czech applicant for Phase 2 (full proposals)

  1. Affidavit of competence;
  2. Updated budget table AZV ČR Application Form)

Other documents

Commission Regulation

Frascati manual

Definition of types of results

The official call documents are available here

Information about the call

The goal of this call isto develop new measures and improve existing ones based on a deeper understanding of the mechanisms underlying the emergence, evolution, selection, persistence, and transmission of antimicrobial resistance within and across the various areas ofthe “One Health”approach.   

To address these challenges, transnational research projects focusing on the following thematic areas will be supported:

  • Topic 1: 

A model of AMR transmission dynamics to predict the risk of AMR emergence and spread, to support decision-making by public authorities.

  • Topic 2: 

Understand and characterize the role of host commensal microorganisms (including fungi) in the dynamics of antimicrobial resistance (AMR) and develop solutions aimed at selectively decolonizing resistant organisms in the host (humans and animals) to prevent transmission.

  • Topic 3:

Develop or improve tools and methods to reduce resistant bacteria, fungi, and resistance genes in environmental hotspots, and investigate the impact of these tools and methods on the transmission of antimicrobial resistance (AMR).

Czech applicants may participate in all three of the above-mentioned topics. However, national funding is limited to the field of human health.

Size of the project consortium

Each project consortium must includeat least 3 eligible partners applying for funding from3 different eligible countries—at least 2of which must be EU Member States or associated countries.The maximum number of partnersin a consortiumis 6, including those who do not apply for funding. This number may be increasedto 7. The number of collaborators must notexceed the number of partners eligible for funding.

Project consortia that advance to the second round of the call (the “full proposal” stage) have the option to expand their original compositionby adding one new partner fromanunder-subscribedfunding organization. Even after this expansion, the total number of partners in the consortium must not exceed8.

List of participating countries:

Australia (NHMRC), Austria (FWF), Belgium (FNRS, FWO, SPW), Canada (CIHR), the Czech Republic (MZČR/AZVČR), Denmark (IFD), Estonia (REM), France (ANR), Germany (BMFTR/DLR), Hungary (NKFIH), Ireland (DAFM, TÉ-RI, HRB), Israel (CSO-MOH), Italy (IT-MoH, FRRB), Latvia (LZP), Lithuania (LMT), Malta (XM), Moldova (NARD), the Netherlands (NWO, ZonMw), Norway (RCN), Poland (NCN), Slovakia (CVTI SR), Spain (IACS, AEI, ISCIII), Sweden (SRC), Switzerland (SNSF), Turkey (TÜBITAK), United Kingdom (MRC-UKRI, DHCS).

*The list of participating countries is current as of November 18, 2026.

Call rules:

The call is governed by transnational rules common to applicants from all participating countries. In addition to the transnational rules, Czech applicants must also comply with the national conditions set by the relevant national provider. Applicants participating in applied research projects will therefore have to comply with national conditions based on Sub-programme 3: European Partnerships in Health.

Contact person:

Mgr. Monika Kocmanová
Email: 
Phone: +420 778 973 186

You can also submit questions about the transnational call via email: .

Attachments

Terms-and-Conditions-Participation-_OHAMRCall2027_Final.pdf(873.75 KB)

Affidavit-of-the-Bidder-PO-1-2.docx(28.33 KB)

Affidavit-of-the-Applicant-FO-1-2.docx(25.68 KB)

Affidavit-for-Research-Organizations-1-2.docx(25.99 KB)

Affidavit-Regarding-the-Composition-of-the-Consortium-1-2.docx(317.34 KB)

Application-Form_European-Partnerships_Both-Rounds_JTC-2027_FINAL-2.xlsx(99.69 KB)

Regulations-Commission-1-2.pdf(17.55 MB)